Review



human interleukin 4 il 4  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Miltenyi Biotec human interleukin 4 il 4
    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 <t>and</t> <t>IL-4</t> (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.
    Human Interleukin 4 Il 4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 140 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/Human+IL-4%2C+premium+grade/pmc13314794-30-0-4
    Average 96 stars, based on 140 article reviews
    human interleukin 4 il 4 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    1) Product Images from "In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platform"

    Article Title: In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platform

    Journal: iScience

    doi: 10.1016/j.isci.2026.116416

    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 and IL-4 (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.
    Figure Legend Snippet: Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 and IL-4 (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.

    Techniques Used: Cell Culture, Immunostaining, Imaging, Cell Based Assay, Luminex, Multiplex Assay, MANN-WHITNEY

    Related Articles

    Concentration Assay:

    Article Title: Monocyte infiltration induces CNS arginine catabolism to fuel neuroinflammation.
    Article Snippet: Three days later, cells were washed once with prewarmed PBS and detached using prewarmed CellStripper (Corning, 15313661). .. Cells were replated at a concentration of 1 million cells per ml in 12- or 24-well plates (Costar, 3737) and stimulated with 100 ng ml−1 LPS (Invivogen, tlrl-3pelps), 20 ng ml−1 IFNγ (Miltenyi Biotec, 130-105-774), 20 ng ml−1 GM-CSF (R&D Systems, 415-ML-050), 20 ng ml−1 IL-4 (Miltenyi Biotec, 130-097-761) and 20 ng ml−1 IL-13 (Miltenyi Biotec, 130-094-070). ..

    Article Title: Ex vivo-generated conventional dendritic cells type 1 and type 2 from blood progenitors induce potent antigen-specific T-cell immunity
    Article Snippet: .. To this end, expanding cells were washed and replated at a cell concentration ranging from 6–8 × 105 cells/ml in T75 flasks using CellGenix® GMP DC-medium (Sartorius CellGenix) supplemented with 2% HS, 1 μM SR1, 50μg/ml ascorbic acid, 100 U/ml FLT3L (130-096-477, Miltenyi Biotec), 800U/ml GM-CSF (130-093-867, Miltenyi Biotec), 1000 U/ml IFN-a2 (130-093-874, Miltenyi Biotec), and 100 U/ml IL-4 (130-093-924, Miltenyi Biotec). .. On day 14, cultures were supplemented with fresh media (25% of the volume used on day 10) prepared with CellGenix® GMP DC medium containing 2% HS, 50 μg/ml ascorbic acid, 200 U/ml FLT3L, 1600 U/ml GM-CSF, 2000U/ml IFN-α2, and 200 U/ml IL-4.

    Activation Assay:

    Article Title: Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoids.
    Article Snippet: .. Pilot-1 activation supplements included 100 ng/mL recombinant human MEGACD40L (Enzo, ALX-522-110-C010), 2.5 μg/mL CpG ODN2006 (Adipogen, ODN2006-1), 50 ng/mL IL-2 (Peprotech, 200-02), 10 ng/mL IL-4 (Miltenyi, 130-093-922). .. Pilot-1 activation supplements included 100 ng/mL recombinant human MEGACD40L (Enzo, ALX-522-110-C010), 2.5 μg/mL CpG ODN2006 (Adipogen, ODN2006-1), 50 ng/mL IL-2 (Peprotech, 200-02), 10 ng/mL IL-4 (Miltenyi, 130-093-922).

    Recombinant:

    Article Title: Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoids.
    Article Snippet: .. Pilot-1 activation supplements included 100 ng/mL recombinant human MEGACD40L (Enzo, ALX-522-110-C010), 2.5 μg/mL CpG ODN2006 (Adipogen, ODN2006-1), 50 ng/mL IL-2 (Peprotech, 200-02), 10 ng/mL IL-4 (Miltenyi, 130-093-922). .. Pilot-1 activation supplements included 100 ng/mL recombinant human MEGACD40L (Enzo, ALX-522-110-C010), 2.5 μg/mL CpG ODN2006 (Adipogen, ODN2006-1), 50 ng/mL IL-2 (Peprotech, 200-02), 10 ng/mL IL-4 (Miltenyi, 130-093-922).

    Isolation:

    Article Title: MYC Overexpression Confers Sensitivity to TACC3 Inhibition for Triple-Negative Breast Cancer
    Article Snippet: CD14+ monocytes were isolated using positive magnetic separation according to the manufacturer’s protocol (Miltenyi Biotec) for in vitro generation of dendritic cells. .. For Mo-DC generation, isolated cells were cultured for 5 days in complete RPMI medium (31870074, Gibco) supplemented with 10% 56°C heat-inactivated (30’) FBS (25-079-CV, Corning), 100 U penicillin-streptomycin (15140-122, Gibco), 2mM L-Glutamine (25030-024, Gibco), 100ng/mL GM-CSF (130-093-864, Miltenyi Biotec) and 100ng/mL IL-4 (130-093-920, Miltenyi Biotec). ..

    Article Title: OKN4395, a first-in-class EP2/EP4/DP1 triple antagonist reprograms prostanoid-driven immunosuppression to restore antitumor immunity
    Article Snippet: IFNγ levels in the cell culture supernatants were measured by U-PLEX assay (K15067M-2, MSD) or Lumit Immunoassay (W6041, Promega). .. Monocytes were isolated from fresh healthy donor PBMCs using CD14 microbeads (130-050-201, Miltenyi Biotech) and cultured for 6-7 days with 50ng/ml IL-4 (130-094-117, Miltenyi Biotech) and 10ng/ml GM-CSF (130-093-867, Miltenyi Biotech). .. Differentiated MoDCs were cultured at a 1:10 MoDC:T cell ratio with allogeneic Pan T cells isolated from frozen healthy donor PBMCs in the presence of 5ug/ml anti-CD3 antibody (16-0037-85, Thermo Fisher Scientific), 500nM PGE2 (2296/10, biotechne) / 1000nM PGD2 (12010, Cayman) / 10μM OKN4395 / 10 μg/ml Pembrolizumab (aRMP Keytruda, Evidentic) for 6-7 days.

    Cell Culture:

    Article Title: MYC Overexpression Confers Sensitivity to TACC3 Inhibition for Triple-Negative Breast Cancer
    Article Snippet: CD14+ monocytes were isolated using positive magnetic separation according to the manufacturer’s protocol (Miltenyi Biotec) for in vitro generation of dendritic cells. .. For Mo-DC generation, isolated cells were cultured for 5 days in complete RPMI medium (31870074, Gibco) supplemented with 10% 56°C heat-inactivated (30’) FBS (25-079-CV, Corning), 100 U penicillin-streptomycin (15140-122, Gibco), 2mM L-Glutamine (25030-024, Gibco), 100ng/mL GM-CSF (130-093-864, Miltenyi Biotec) and 100ng/mL IL-4 (130-093-920, Miltenyi Biotec). ..

    Article Title: OKN4395, a first-in-class EP2/EP4/DP1 triple antagonist reprograms prostanoid-driven immunosuppression to restore antitumor immunity
    Article Snippet: IFNγ levels in the cell culture supernatants were measured by U-PLEX assay (K15067M-2, MSD) or Lumit Immunoassay (W6041, Promega). .. Monocytes were isolated from fresh healthy donor PBMCs using CD14 microbeads (130-050-201, Miltenyi Biotech) and cultured for 6-7 days with 50ng/ml IL-4 (130-094-117, Miltenyi Biotech) and 10ng/ml GM-CSF (130-093-867, Miltenyi Biotech). .. Differentiated MoDCs were cultured at a 1:10 MoDC:T cell ratio with allogeneic Pan T cells isolated from frozen healthy donor PBMCs in the presence of 5ug/ml anti-CD3 antibody (16-0037-85, Thermo Fisher Scientific), 500nM PGE2 (2296/10, biotechne) / 1000nM PGD2 (12010, Cayman) / 10μM OKN4395 / 10 μg/ml Pembrolizumab (aRMP Keytruda, Evidentic) for 6-7 days.

    Knock-Out:

    Article Title: The mutational landscape of STING-induced immunity.
    Article Snippet: THP-1 cells were cultured in Roswell Park Memorial Institute 1640 Medium (RPMI 1640) (Thermo Fisher Scientific, 21875034) containing 10% (v/v) heat-inactivated FBS, 25 mM HEPES (BioConcept, 5-31F00-H), 2 mM l-glutamine and 1% (v/v) penicillin–streptomycin. .. THP-1 STING1 knockout cells reconstituted with eGFP-tagged wild-type or mutant STING were treated 100 ng ml−1 GM-CSF (Miltenyi Biotec, 130-095-372) and 100 ng ml−1 IL-4 (Miltenyi Biotec, 130-093-917) for 5 days to induce differentiation into dendritic cell-like cells. ..

    Mutagenesis:

    Article Title: The mutational landscape of STING-induced immunity.
    Article Snippet: THP-1 cells were cultured in Roswell Park Memorial Institute 1640 Medium (RPMI 1640) (Thermo Fisher Scientific, 21875034) containing 10% (v/v) heat-inactivated FBS, 25 mM HEPES (BioConcept, 5-31F00-H), 2 mM l-glutamine and 1% (v/v) penicillin–streptomycin. .. THP-1 STING1 knockout cells reconstituted with eGFP-tagged wild-type or mutant STING were treated 100 ng ml−1 GM-CSF (Miltenyi Biotec, 130-095-372) and 100 ng ml−1 IL-4 (Miltenyi Biotec, 130-093-917) for 5 days to induce differentiation into dendritic cell-like cells. ..



    Similar Products

    99
    NSJ Bioreagents il-4 antibody
    Il 4 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/IL-4+Antibody/custom%40v8351%4042658679
    Average 99 stars, based on 1 article reviews
    il-4 antibody - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    95
    MedChemExpress interleukin 4
    Interleukin 4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/IL-4%2C+Mouse/pmc13439409-114-41-44
    Average 95 stars, based on 1 article reviews
    interleukin 4 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec human interleukin 4 il 4
    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 <t>and</t> <t>IL-4</t> (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.
    Human Interleukin 4 Il 4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/Human+IL-4%2C+premium+grade/pmc13314794-30-0-4
    Average 96 stars, based on 1 article reviews
    human interleukin 4 il 4 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    Guangzhou JET Bio-Filtration mouse il-4 (interleukin 4) elisa kit
    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 <t>and</t> <t>IL-4</t> (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.
    Mouse Il 4 (Interleukin 4) Elisa Kit, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/Mouse+IL-4+(Interleukin+4)+ELISA+Kit/custom%40e-el-m0043%4041886005
    Average 94 stars, based on 1 article reviews
    mouse il-4 (interleukin 4) elisa kit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Thermo Fisher interleukin 4 il 4
    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 <t>and</t> <t>IL-4</t> (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.
    Interleukin 4 Il 4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/Interleukin+4%2C+human/pmc13091955-314-0-30
    Average 94 stars, based on 1 article reviews
    interleukin 4 il 4 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Guangzhou JET Bio-Filtration human il-1β (interleukin 1 beta) elisa kit
    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 <t>and</t> <t>IL-4</t> (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.
    Human Il 1β (Interleukin 1 Beta) Elisa Kit, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/Human+IL-1%CE%B2+(Interleukin+1+Beta)+ELISA+Kit/custom%40e-el-h0149%4042305711
    Average 94 stars, based on 1 article reviews
    human il-1β (interleukin 1 beta) elisa kit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    97
    MedChemExpress il-4, human
    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 <t>and</t> <t>IL-4</t> (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.
    Il 4, Human, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il+4/IL-4%2C+Human/custom%40hy-p70445%4042462890
    Average 97 stars, based on 1 article reviews
    il-4, human - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    Image Search Results


    Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 and IL-4 (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.

    Journal: iScience

    Article Title: In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platform

    doi: 10.1016/j.isci.2026.116416

    Figure Lengend Snippet: Induction of LFs and anti-RABV-G IgG production by SAM-LNP1 in human LF chips (A) Schematic of the LF Chip created with monocytes and conditioned medium from the intramuscular vaccination-mimicking module created with BioRender.com . (B) Representative 3D confocal microscopic stacks showing pseudo-colored follicles (blue) and cell nuclei (green) present within extracellular matrix (ECM) gels cultured for 4 days within a perfused LF Chip when vaccinated with SAM-LNP1 in the absence or presence of IL-2 and IL-4 (SAM-LNP1 + IL-2&IL-4); scale bars, 100 μm. (C) Quantification of the number (left) and size (right) of LFs in LF chips of one donor based on immunostaining followed by confocal imaging. Each data point represents one field of view (left) or an individual follicle (right); 2 independent chips were analyzed per condition. (D) Anti-RABV-G IgG levels in effluents of no treatment LF chips or chips vaccinated with or without IL-2 and IL-4 and cultured for 14 days were detected using a cell-based assay; 3–4 independent chips were analyzed per condition. (E) Quantification of the number (left) and size (right) of LFs in LF chips from four different donors, with each color representing a different donor. Each data point corresponds to one field of view (left) or an individual follicle (right). (F) Anti-RABV-G IgG levels in effluents of LF chips. Each data point represents one chip, with different symbols indicating chips from three independent donors. (G) Anti-RABV-G IgG levels in effluents of LF chips seeded with naive B + bulk T + monocyte mixture. Each data point represents one chip, with different symbols indicating chips from three independent donors. (H) Heatmap showing average log2 fold changes in cytokine levels in the effluents of three LF chips created using bulk lymphocytes from donors whose prior exposure to rabies was unknown, measured using a Luminex Multiplex Assay at various time points (4, 7, 15, 22, and 28 days post-vaccination) compared to the average levels of each cytokine found at day 1. Representative results from one donor are shown in (B)–(D) and (H), with similar outcomes observed in two donors. Data shown are mean ± SD; (C, left; D; and E) one way ANOVA test followed by Tukey’s multiple comparisons test, (C, right; and E) Mann-Whitney U test, (F and G) Welch’s t test.

    Article Snippet: Human Interleukin-4 (IL-4) , Miltenyi Biotec , 130-093-922.

    Techniques: Cell Culture, Immunostaining, Imaging, Cell Based Assay, Luminex, Multiplex Assay, MANN-WHITNEY